New drug approvals: June 2018
June has seen a plethora of new drug approvals, including the US FDA's first approval of cannabidiol to treat seizures associated with both Lennox-Gastaut and Dravet syndrome; find out more in this round-up of the new therapies on the market.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.